Skip to main content
Erschienen in: Journal of Artificial Organs 4/2011

01.12.2011 | Original Article

Neointima-inducing inflow cannula with titanium mesh for left ventricular assist device

verfasst von: Yukiko Yamada, Tomohiro Nishinaka, Toshihide Mizuno, Yoshiyuki Taenaka, Eisuke Tatsumi, Kenji Yamazaki

Erschienen in: Journal of Artificial Organs | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The formation of wedge thrombus is a crucial problem in any left ventricular assist device (LVAD) with a left ventricle apical inflow cannula. We therefore developed a new titanium mesh wrapped inflow cannula expecting to induce autologous neointima to avoid such wedge thrombus formation. We performed animal experiments to evaluate the feasibility of this newly developed inflow cannula with titanium mesh for the induction of autologous neointima. Four calves were implanted with the inflow cannula as well as an EVAHEART centrifugal pump LVAD (Sun Medical Technology Research Corp., Nagano, Japan) for a duration of about 2 months. The titanium mesh was enveloped with neointimal tissue grown from the ventricular endocardium. There was no thrombus formation in any of the blood pumps or around the outside of the inflow cannulas. The histological findings showed that the neointimal tissue consisted of a layer of endothelial cells and fibroblasts. The newly developed inflow cannula using a titanium mesh induces autologous neointima formation, avoiding wedge thrombus formation.
Literatur
1.
Zurück zum Zitat Navia JL, McCarthy PM, Hoercher KJ, Smedira NG, Banbury MK, Blackstone EH. Do left ventricular assist device bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg. 2002;74:2051–63.PubMedCrossRef Navia JL, McCarthy PM, Hoercher KJ, Smedira NG, Banbury MK, Blackstone EH. Do left ventricular assist device bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg. 2002;74:2051–63.PubMedCrossRef
2.
Zurück zum Zitat Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P. Long-term use of a left ventricular assist device for end-stage heart failure. NEJM. 2001;345:1435–43.PubMedCrossRef Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P. Long-term use of a left ventricular assist device for end-stage heart failure. NEJM. 2001;345:1435–43.PubMedCrossRef
3.
Zurück zum Zitat Frazier OH, Baldwin RT, Eskin SG, Duncan JM. Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex Heart Inst J. 1993;20:78–82.PubMed Frazier OH, Baldwin RT, Eskin SG, Duncan JM. Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex Heart Inst J. 1993;20:78–82.PubMed
4.
Zurück zum Zitat Rose EA, Levin HR, Oz MC, Frazier OH, Macmanus QW, Burton NA, Lefrak EA. Artificial circulatory support with textured interior surface. A counterintuitive approach to minimizing thromboembolism. Circulation. 1994;90:II87–91.PubMed Rose EA, Levin HR, Oz MC, Frazier OH, Macmanus QW, Burton NA, Lefrak EA. Artificial circulatory support with textured interior surface. A counterintuitive approach to minimizing thromboembolism. Circulation. 1994;90:II87–91.PubMed
5.
Zurück zum Zitat Frazier OH, Gemmato CG, Myers TJ, Gregoric ID, Radovancevic B, Loyalka P, Kar BK. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J. 2007;34:275–81.PubMed Frazier OH, Gemmato CG, Myers TJ, Gregoric ID, Radovancevic B, Loyalka P, Kar BK. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J. 2007;34:275–81.PubMed
6.
Zurück zum Zitat Schmid C, Jurmann M, Birnbaum D, Colombo T, Falk V, Feltrin G, Garatti A, Genoni M, Gerosa G, Göttel P, Gummert J, Halfmann R, Hammel D, Hennig E, Kaufmann F, Lanfranconi M, Meyns B, Mohr F, Müller J, Nikolov D, Rucinskas K, Scheld HH, Schmid FX, Schneider M, Sirvydis V, Tandler R, Vitali E, Vlasselaers D, Weyand M, Wilhelm M, Hetzer R. Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis. J Heart Lung Transplant. 2008;27:253–60.PubMedCrossRef Schmid C, Jurmann M, Birnbaum D, Colombo T, Falk V, Feltrin G, Garatti A, Genoni M, Gerosa G, Göttel P, Gummert J, Halfmann R, Hammel D, Hennig E, Kaufmann F, Lanfranconi M, Meyns B, Mohr F, Müller J, Nikolov D, Rucinskas K, Scheld HH, Schmid FX, Schneider M, Sirvydis V, Tandler R, Vitali E, Vlasselaers D, Weyand M, Wilhelm M, Hetzer R. Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis. J Heart Lung Transplant. 2008;27:253–60.PubMedCrossRef
7.
Zurück zum Zitat Schmid C, Weyand M, Nabavi DG, Hammel D, Deng MC, Ringelstein EB, Scheld HH. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg. 1998;65:1703–10.PubMedCrossRef Schmid C, Weyand M, Nabavi DG, Hammel D, Deng MC, Ringelstein EB, Scheld HH. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg. 1998;65:1703–10.PubMedCrossRef
8.
Zurück zum Zitat Mussivand T, Hetzer R, Vitali E, Meyns B, Noirhomme P, Koerfer R, El-Banayosy A, Wolner E, Wieselthaler G, Reichart B, Uberfuhr P, Halfmann R, Portner P. Clinical results with an ePTFE inflow conduit for mechanical circulatory support. J Heart Lung Transplant. 2004;23:1366–70.PubMedCrossRef Mussivand T, Hetzer R, Vitali E, Meyns B, Noirhomme P, Koerfer R, El-Banayosy A, Wolner E, Wieselthaler G, Reichart B, Uberfuhr P, Halfmann R, Portner P. Clinical results with an ePTFE inflow conduit for mechanical circulatory support. J Heart Lung Transplant. 2004;23:1366–70.PubMedCrossRef
9.
Zurück zum Zitat Frazier OH, Forrester MD, Gemmato C, Gregoric ID. Urgent pump exchange for stroke resulting from a distorted HeartMate XVE inflow conduit. J Heart Lung Transplant. 2007;26:646–8.PubMedCrossRef Frazier OH, Forrester MD, Gemmato C, Gregoric ID. Urgent pump exchange for stroke resulting from a distorted HeartMate XVE inflow conduit. J Heart Lung Transplant. 2007;26:646–8.PubMedCrossRef
10.
Zurück zum Zitat Kurihara C, Ono M, Nishimura T, Saito A, Taketani T, Hisagi M, Nawata K, Kinoshita O, Morota T, Motomura N, Kyo S. Use of DuraHeart support for more than 1 year as the first successful bridge to heart transplantation in Japan. J Artif Organs. 2010;14:67–9. Kurihara C, Ono M, Nishimura T, Saito A, Taketani T, Hisagi M, Nawata K, Kinoshita O, Morota T, Motomura N, Kyo S. Use of DuraHeart support for more than 1 year as the first successful bridge to heart transplantation in Japan. J Artif Organs. 2010;14:67–9.
11.
Zurück zum Zitat Yamazaki K, Litwak P, Tagusari O, Mori T, Kono K, Kameneva M, Watach M, Gordon L, Miyagishima M, Tomioka J, Umezu M, Outa E, Antaki JF, Kormos RL, Koyanagi H, Griffith B. An implantable centrifugal blood pump with a recirculating purge system (Cool-seal system). Artif Organs. 1998;22:466–74.PubMedCrossRef Yamazaki K, Litwak P, Tagusari O, Mori T, Kono K, Kameneva M, Watach M, Gordon L, Miyagishima M, Tomioka J, Umezu M, Outa E, Antaki JF, Kormos RL, Koyanagi H, Griffith B. An implantable centrifugal blood pump with a recirculating purge system (Cool-seal system). Artif Organs. 1998;22:466–74.PubMedCrossRef
12.
Zurück zum Zitat Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 2007;55:158–62.PubMedCrossRef Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 2007;55:158–62.PubMedCrossRef
13.
Zurück zum Zitat Dasse KA, Chipman SD, Sheaman CN, Levine AH, Frazier OH. Clinical experience with textured blood contacting surfaces in ventricular assist devices. Trans Am Soc Artif Intern Organs. 1987;33:418–25. Dasse KA, Chipman SD, Sheaman CN, Levine AH, Frazier OH. Clinical experience with textured blood contacting surfaces in ventricular assist devices. Trans Am Soc Artif Intern Organs. 1987;33:418–25.
14.
Zurück zum Zitat Gordon PB, Sussman II, Hatcher VB. Long-term culture of human endothelial cells. In vitro Cell Dev Biol. 1983;19:661–71. Gordon PB, Sussman II, Hatcher VB. Long-term culture of human endothelial cells. In vitro Cell Dev Biol. 1983;19:661–71.
15.
Zurück zum Zitat Hoshi H, WcKeehan W. Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium. In vitro Cell Dev Biol. 1986;22(1):51–6.PubMedCrossRef Hoshi H, WcKeehan W. Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium. In vitro Cell Dev Biol. 1986;22(1):51–6.PubMedCrossRef
16.
Zurück zum Zitat Berger K, Sauvage LR, Rao AM, Wood SJ. Healing of arterial prostheses in man: its incompleteness. Ann Surg. 1972;175:118–27.PubMedCrossRef Berger K, Sauvage LR, Rao AM, Wood SJ. Healing of arterial prostheses in man: its incompleteness. Ann Surg. 1972;175:118–27.PubMedCrossRef
17.
Zurück zum Zitat Sigler M, Jux C, Ewert P. Histopathological workup of an amplatzer atrial septal defect occluder after surgical removal. Pediatr Cardiol. 2006;27:775–6.PubMedCrossRef Sigler M, Jux C, Ewert P. Histopathological workup of an amplatzer atrial septal defect occluder after surgical removal. Pediatr Cardiol. 2006;27:775–6.PubMedCrossRef
18.
19.
Zurück zum Zitat Foth R, Quentin T, Michel-Behnke I, Vogt M, Kriebel T, Kreischer A, Ruschewski W, Paul T, Sigler T. Immunohistochemical characterization of neotissues and tissue reactions to septal defect occlusion devices. Circ Cardiovasc Intervent. 2009;2:90–6.CrossRef Foth R, Quentin T, Michel-Behnke I, Vogt M, Kriebel T, Kreischer A, Ruschewski W, Paul T, Sigler T. Immunohistochemical characterization of neotissues and tissue reactions to septal defect occlusion devices. Circ Cardiovasc Intervent. 2009;2:90–6.CrossRef
Metadaten
Titel
Neointima-inducing inflow cannula with titanium mesh for left ventricular assist device
verfasst von
Yukiko Yamada
Tomohiro Nishinaka
Toshihide Mizuno
Yoshiyuki Taenaka
Eisuke Tatsumi
Kenji Yamazaki
Publikationsdatum
01.12.2011
Verlag
Springer Japan
Erschienen in
Journal of Artificial Organs / Ausgabe 4/2011
Print ISSN: 1434-7229
Elektronische ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-011-0586-4

Weitere Artikel der Ausgabe 4/2011

Journal of Artificial Organs 4/2011 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.